Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Satterwhite, S. Zimm (1984)
The use of scalp hypothermia in the prevention of doxorubicin‐induced hair lossCancer, 54
Symonds Rp, McCormick Cv, Maxted Kj (1986)
Adriamycin alopecia prevented by cold air scalp cooling.American Journal of Clinical Oncology, 9
R. Gregory, T. Cooke, J. Middleton, R. Buchanan, C. Williams (1982)
Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.British Medical Journal (Clinical research ed.), 284
G. Edelstyn, Muriel Macdonald, K. Macrae (1977)
DOXORUBICIN-INDUCED HAIR LOSS AND POSSIBLE MODIFICATION BY SCALP COOLINGThe Lancet, 310
J. Anderson, J. Hunt, I. Smith (1981)
Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer.British Medical Journal (Clinical research ed.), 282
J. Dean, S. Salmon, K. Griffith (1979)
Prevention of doxorubicin-induced hair loss with scalp hypothermia.The New England journal of medicine, 301 26
Symonds Symonds, McCormick McCormick, Maxted Maxted (1986)
Adriamycin alopecia prevented by cold air collingAmerican Journal of Clinical oncology, 9
R. Benjamin, P. Wiernik, N. Bachur (1974)
Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage scheduleCancer, 33
Guy Guy, Parker Parker, Shah Shah, Geddes Geddes (1988)
Scalp cooling by thermocirculatorLancet, 1
S. Daenen, H. Vries-Hospers (1988)
CURE OF PSEUDOMONAS AERUGINOSA INFECTION IN NEUTROPENIC PATIENTS BY CONTINUOUS INFUSION OF CEFTAZIDIMEThe Lancet, 331
J. Dean, K. Griffith, T. Cetas, C. Mackel, S. Jones, S. Salmon (1983)
Scalp hypothermia: a comparison of ice packs and the Kold Kap in the prevention of doxorubicin-induced alopecia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1 1
The use of a cold‐air scalp‐cooling system to prevent alopecia following administration of anthracycline chemotherapy is described. The unit used is mounted on a four‐wheeled trolley and is highly mobile. Twenty‐four patients with advanced breast cancer received epirubicin chemotherapy, 14 at a dose of 50 mg/m2, and 10 at a dose of 100 mg/m2. All 10 patients receiving 100 mg/m2 developed total alopecia; by contrast, only two out of 14 receiving 50 mg/m2 had alopecia, while the remaining 12 retained their hair. Patients not receiving scalp‐cooling inevitably developed total alopecia after three pulses of epirubicin.
European Journal of Cancer Care – Wiley
Published: Dec 1, 1992
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.